Nuclear receptors reverse McGarry's vicious cycle to insulin resistance

Cell Metabolism

Volumn 15, Issue 5, 2012, Pages 615-622

  Moore, David D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; INSULIN; LIVER RECEPTOR HOMOLOG 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

FATTY LIVER; GLUCONEOGENESIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; STEATOSIS;

ANIMALS; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; MICE; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84860468405     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.03.016     Document Type: Review

References (125)

1. M.F. Abdelmalek, and A.M. Diehl Nonalcoholic fatty liver disease as a complication of insulin resistance Med. Clin. North Am. 91 2007 1125 1149 ix (Pubitemid 47625434)
2. A. Amaro, E. Fabbrini, M. Kars, P. Yue, K. Schechtman, G. Schonfeld, and S. Klein Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia Gastroenterology 139 2010 149 153
3. J. Amengual, J. Ribot, M.L. Bonet, and A. Palou Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice Cell Physiol. Biochem. 25 2010 657 666
4. B.S. Amorim, C.B. Ueta, B.C. Freitas, R.J. Nassif, C.H. Gouveia, M.A. Christoffolete, A.S. Moriscot, C.L. Lancelloti, F. Llimona, and H.V. Barbeiro A TRbeta-selective agonist confers resistance to diet-induced obesity J. Endocrinol. 203 2009 291 299
5. B. Angelin, and M. Rudling Lipid lowering with thyroid hormone and thyromimetics Curr. Opin. Lipidol. 21 2010 499 506
6. Q.M. Anstee, and R.D. Goldin Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int. J. Exp. Pathol. 87 2006 1 16
7. G.D. Barish, V.A. Narkar, and R.M. Evans PPAR delta: a dagger in the heart of the metabolic syndrome J. Clin. Invest. 116 2006 590 597 (Pubitemid 43326863)
8. D.C. Berry, and N. Noy All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor Mol. Cell. Biol. 29 2009 3286 3296
9. S.B. Biddinger, K. Almind, M. Miyazaki, E. Kokkotou, J.M. Ntambi, and C.R. Kahn Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome Diabetes 54 2005 1314 1323 (Pubitemid 40586659)
10. G. Boden Obesity, insulin resistance and free fatty acids Curr. Opin. Endocrinol. Diabetes Obes. 18 2011 139 143
11. A.L. Bookout, Y. Jeong, M. Downes, R.T. Yu, R.M. Evans, and D.J. Mangelsdorf Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network Cell 126 2006 789 799 (Pubitemid 44233630)
12. M.R. Briggs, C. Yokoyama, X. Wang, M.S. Brown, and J.L. Goldstein Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence J. Biol. Chem. 268 1993 14490 14496 (Pubitemid 23195580)
13. M.S. Brown, and J.L. Goldstein Selective versus total insulin resistance: a pathogenic paradox Cell Metab. 7 2008 95 96 (Pubitemid 351168559)
14. G. Bryzgalova, S. Effendic, A. Khan, S. Rehnmark, P. Barbounis, J. Boulet, G. Dong, R. Singh, S. Shapses, and J. Malm Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141 J. Steroid Biochem. Mol. Biol. 111 2008 262 267
15. G. Bryzgalova, L. Lundholm, N. Portwood, J.A. Gustafsson, A. Khan, S. Efendic, and K. Dahlman-Wright Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice Am. J. Physiol. Endocrinol. Metab. 295 2008 E904 E912
16. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, J. Lee, and S.E. Shoelson Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat. Med. 11 2005 183 190 (Pubitemid 40321354)
17. G. Cao, Y. Liang, C.L. Broderick, B.A. Oldham, T.P. Beyer, R.J. Schmidt, Y. Zhang, K.R. Stayrook, C. Suen, and K.A. Otto Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis J. Biol. Chem. 278 2003 1131 1136 (Pubitemid 36790794)
18. G.R. Chang, Y.S. Chiu, Y.Y. Wu, W.Y. Chen, J.W. Liao, T.H. Chao, and F.C. Mao Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice J. Pharmacol. Sci. 109 2009 496 503
19. L.C. Chao, K. Wroblewski, Z. Zhang, L. Pei, L. Vergnes, O.R. Ilkayeva, S.Y. Ding, K. Reue, M.J. Watt, and C.B. Newgard Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77 Diabetes 58 2009 2788 2796
20. S.S. Choi, and A.M. Diehl Hepatic triglyceride synthesis and nonalcoholic fatty liver disease Curr. Opin. Lipidol. 19 2008 295 300 (Pubitemid 351653569)
21. S. Cipriani, A. Mencarelli, G. Palladino, and S. Fiorucci FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats J. Lipid Res. 51 2010 771 784
22. S.R. Commerford, L. Vargas, S.E. Dorfman, N. Mitro, E.C. Rocheford, P.A. Mak, X. Li, P. Kennedy, T.L. Mullarkey, and E. Saez Dissection of the insulin-sensitizing effect of liver X receptor ligands Mol. Endocrinol. 21 2007 3002 3012 (Pubitemid 350223510)
23. J.M. Del Bas, M.L. Ricketts, I. Baiges, H. Quesada, A. Ardevol, M.J. Salvadó, G. Pujadas, M. Blay, L. Arola, and C. Bladé Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner Mol. Nutr. Food Res. 52 2008 1172 1181
24. G. Dimitriadis, B. Baker, H. Marsh, L. Mandarino, R. Rizza, R. Bergman, M. Haymond, and J. Gerich Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans Am. J. Physiol. 248 1985 E593 E601
25. B. Dong, P.K. Saha, W. Huang, W. Chen, L.A. Abu-Elheiga, S.J. Wakil, R.D. Stevens, O. Ilkayeva, C.B. Newgard, L. Chan, and D.D. Moore Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease Proc. Natl. Acad. Sci. USA 106 2009 18831 18836
26. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J. Clin. Invest. 115 2005 1343 1351 (Pubitemid 40629054)
27. M.B. Elam, C. Yellaturu, G.E. Howell, X. Deng, G.S. Cowan, P. Kumar, E.A. Park, M.L. Hiler, H.G. Wilcox, and T.A. Hughes Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling Metabolism 59 2010 587 598
28. M.D. Erion, E.E. Cable, B.R. Ito, H. Jiang, J.M. Fujitaki, P.D. Finn, B.H. Zhang, J. Hou, S.H. Boyer, P.D. van Poelje, and D.L. Linemeyer Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index Proc. Natl. Acad. Sci. USA 104 2007 15490 15495 (Pubitemid 47502944)
29. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
30. P. Ferré, and F. Foufelle Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c Diabetes Obes. Metab. 12 Suppl 2 2010 83 92
31. M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, and G. Leibowitz mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes Diabetes 57 2008 945 957
32. H. Gao, S. Fält, A. Sandelin, J.A. Gustafsson, and K. Dahlman-Wright Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver Mol. Endocrinol. 22 2008 10 22
33. J. Gao, J. He, Y. Zhai, T. Wada, and W. Xie The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity J. Biol. Chem. 284 2009 25984 25992
34. A. Gastaldelli, K. Cusi, M. Pettiti, J. Hardies, Y. Miyazaki, R. Berria, E. Buzzigoli, A.M. Sironi, E. Cersosimo, E. Ferrannini, and R.A. Defronzo Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects Gastroenterology 133 2007 496 506 (Pubitemid 47187337)
35. L.L. Gathercole, and P.M. Stewart Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes J. Steroid Biochem. Mol. Biol. 122 2010 21 27
36. L.E. Gerber, and J.W. Erdman Jr. Changes in lipid metabolism during retinoid administration J. Am. Acad. Dermatol. 6 4 Pt 2, Suppl 1982 664 674 (Pubitemid 12147427)
37. A.S. Greenberg, R.A. Coleman, F.B. Kraemer, J.L. McManaman, M.S. Obin, V. Puri, Q.W. Yan, H. Miyoshi, and D.G. Mashek The role of lipid droplets in metabolic disease in rodents and humans J. Clin. Invest. 121 2011 2102 2110
38. A. Grefhorst, T.H. van Dijk, A. Hammer, F.H. van der Sluijs, R. Havinga, L.M. Havekes, J.A. Romijn, P.H. Groot, D.J. Reijngoud, and F. Kuipers Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice Am. J. Physiol. Endocrinol. Metab. 289 2005 E829 E838
39. R.K. Gupta, M.Z. Vatamaniuk, C.S. Lee, R.C. Flaschen, J.T. Fulmer, F.M. Matschinsky, S.A. Duncan, and K.H. Kaestner The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion J. Clin. Invest. 115 2005 1006 1015 (Pubitemid 40489405)
40. K. Hashimoto, M. Yamada, S. Matsumoto, T. Monden, T. Satoh, and M. Mori Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone Endocrinology 147 2006 4292 4302 (Pubitemid 44268380)
41. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. Defronzo, and J.P. Kirwan Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 2009 337 343
42. B. Herzog, M. Hallberg, A. Seth, A. Woods, R. White, and M.G. Parker The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor Mol. Endocrinol. 21 2007 2687 2697 (Pubitemid 350035151)
43. N. Higuchi, M. Kato, Y. Shundo, H. Tajiri, M. Tanaka, N. Yamashita, M. Kohjima, K. Kotoh, M. Nakamuta, R. Takayanagi, and M. Enjoji Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease Hepatol. Res. 38 2008 1122 1129
44. W.L. Holland, and S.A. Summers Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism Endocr. Rev. 29 2008 381 402 (Pubitemid 351831506)
45. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109 2002 1125 1131 (Pubitemid 34496588)
46. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
47. V.P. Houde, S. Brûlé, W.T. Festuccia, P.G. Blanchard, K. Bellmann, Y. Deshaies, and A. Marette Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue Diabetes 59 2010 1338 1348
48. D. Ingle The production of glycosuria in the normal rat by means of 17-hydroxy-11-dehydrocorticosterone Endocrinology 29 1941 649 652
49. D.J. Ingle, R. Sheppard, J.S. Evans, and M.H. Kuizenga A comparison of adrenal steroid diabetes and pancreatic diabetes in the rat Endocrinology 37 1945 341 356
50. L. Johansson, M. Rudling, T.S. Scanlan, T. Lundåsen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice Proc. Natl. Acad. Sci. USA 102 2005 10297 10302 (Pubitemid 41024974)
51. N.Y. Kalaany, and D.J. Mangelsdorf LXRS and FXR: the yin and yang of cholesterol and fat metabolism Annu. Rev. Physiol. 68 2006 159 191
52. N.Y. Kalaany, K.C. Gauthier, A.M. Zavacki, P.P. Mammen, T. Kitazume, J.A. Peterson, J.D. Horton, D.J. Garry, A.C. Bianco, and D.J. Mangelsdorf LXRs regulate the balance between fat storage and oxidation Cell Metab. 1 2005 231 244 (Pubitemid 43960607)
53. H.L. Kammoun, H. Chabanon, I. Hainault, S. Luquet, C. Magnan, T. Koike, P. Ferré, and F. Foufelle GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice J. Clin. Invest. 119 2009 1201 1215
54. I. Karvonen, J.H. Stengård, R. Huupponen, F.G. Stenbäck, and E.A. Sotaniemi Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus Diabetes Res. 10 1989 85 92 (Pubitemid 19228264)
55. D.E. Kelley, T.M. McKolanis, R.A. Hegazi, L.H. Kuller, and S.C. Kalhan Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance Am. J. Physiol. Endocrinol. Metab. 285 2003 E906 E916
56. H.J. Kim, M. Takahashi, and O. Ezaki Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs J. Biol. Chem. 274 1999 25892 25898
57. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375 (Pubitemid 351615354)
58. B.A. Laffitte, L.C. Chao, J. Li, R. Walczak, S. Hummasti, S.B. Joseph, A. Castrillo, D.C. Wilpitz, D.J. Mangelsdorf, and J.L. Collins Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue Proc. Natl. Acad. Sci. USA 100 2003 5419 5424 (Pubitemid 36542720)
59. J.T. Lahtela, A.J. Arranto, and E.A. Sotaniemi Enzyme inducers improve insulin sensitivity in non-insulin-dependent diabetic subjects Diabetes 34 1985 911 916 (Pubitemid 15016555)
60. F. Lalloyer, and B. Staels Fibrates, glitazones, and peroxisome proliferator-activated receptors Arterioscler. Thromb. Vasc. Biol. 30 2010 894 899
61. H. Lan, M.E. Rabaglia, J.P. Stoehr, S.T. Nadler, K.L. Schueler, F. Zou, B.S. Yandell, and A.D. Attie Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility Diabetes 52 2003 688 700 (Pubitemid 36323576)
62. J.M. Lee, Y.K. Lee, J.L. Mamrosh, S.A. Busby, P.R. Griffin, M.C. Pathak, E.A. Ortlund, and D.D. Moore A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects Nature 474 2011 506 510
63. M. Lehrke, and M.A. Lazar The many faces of PPARgamma Cell 123 2005 993 999
64. S. Li, M.S. Brown, and J.L. Goldstein Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis Proc. Natl. Acad. Sci. USA 107 2010 3441 3446
65. Y. Li, S. Xu, M.M. Mihaylova, B. Zheng, X. Hou, B. Jiang, O. Park, Z. Luo, E. Lefai, and J.Y. Shyy AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab. 13 2011 376 388
66. G. Liang, J. Yang, J.D. Horton, R.E. Hammer, J.L. Goldstein, and M.S. Brown Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c J. Biol. Chem. 277 2002 9520 9528 (Pubitemid 34953041)
67. J. Lin, R. Yang, P.T. Tarr, P.H. Wu, C. Handschin, S. Li, W. Yang, L. Pei, M. Uldry, and P. Tontonoz Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP Cell 120 2005 261 273 (Pubitemid 40174768)
68. Y. Liu, C. Yan, Y. Wang, Y. Nakagawa, N. Nerio, A. Anghel, K. Lutfy, and T.C. Friedman Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice Endocrinology 147 2006 5061 5068 (Pubitemid 44790557)
69. C. Long, B. Katzin, and E. Fry The adrenal cortex and carbohydrate metabolism Endocrinology 26 1940 309 344
70. K. Ma, P.K. Saha, L. Chan, and D.D. Moore Farnesoid X receptor is essential for normal glucose homeostasis J. Clin. Invest. 116 2006 1102 1109
71. H. Malhi, and G.J. Gores Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin. Liver Dis. 28 2008 360 369
72. D.C. Manolescu, A. Sima, and P.V. Bhat All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice J. Nutr. 140 2010 311 316
73. F. Mauvais-Jarvis Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity Trends Endocrinol. Metab. 22 2011 24 33
74. J.D. McGarry What if Minkowski had been ageusic? An alternative angle on diabetes Science 258 1992 766 770
75. J.D. McGarry, and D.W. Foster Regulation of hepatic fatty acid oxidation and ketone body production Annu. Rev. Biochem. 49 1980 395 420
76. A. Miura, K. Yamagata, M. Kakei, H. Hatakeyama, N. Takahashi, K. Fukui, T. Nammo, K. Yoneda, Y. Inoue, and F.M. Sladek Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells J. Biol. Chem. 281 2006 5246 5257 (Pubitemid 43847789)
77. M. Monetti, M.C. Levin, M.J. Watt, M.P. Sajan, S. Marmor, B.K. Hubbard, R.D. Stevens, J.R. Bain, C.B. Newgard, and R.V. Farese Sr. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab. 6 2007 69 78 (Pubitemid 46995777)
78. Y.A. Moon, G. Liang, X. Xie, M. Frank-Kamenetsky, K. Fitzgerald, V. Koteliansky, M.S. Brown, J.L. Goldstein, and J.D. Horton The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals Cell Metab. 15 2012 240 246
79. A. Munck Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance Perspect. Biol. Med. 14 1971 265 269
80. Y. Nagai, S. Yonemitsu, D.M. Erion, T. Iwasaki, R. Stark, D. Weismann, J. Dong, D. Zhang, M.J. Jurczak, and M.G. Löffler The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance Cell Metab. 9 2009 252 264
81. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu. Rev. Physiol. 72 2010 219 246
82. A. Paquette, D. Wang, M. Jankowski, J. Gutkowska, and J.M. Lavoie Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver Menopause 15 2008 1169 1175
83. K.G. Park, A.K. Min, E.H. Koh, H.S. Kim, M.O. Kim, H.S. Park, Y.D. Kim, T.S. Yoon, B.K. Jang, and J.S. Hwang Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways Hepatology 48 2008 1477 1486
84. Z. Pataky, E. Bobbioni-Harsch, and A. Golay Open questions about metabolically normal obesity Int. J. Obes. (Lond.) 34 Suppl 2 2010 S18 S23
85. M.A. Pearen, and G.E. Muscat Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease Mol. Endocrinol. 24 2010 1891 1903
86. K.F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R.E. Hendler, and G.I. Shulman Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 2005 603 608 (Pubitemid 40322060)
87. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, and D.M. Sabatini mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway Cell 146 2011 408 420
88. P. Pettinelli, T. Del Pozo, J. Araya, R. Rodrigo, A.V. Araya, G. Smok, A. Csendes, L. Gutierrez, J. Rojas, and O. Korn Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion Biochim. Biophys. Acta 1792 2009 1080 1086
89. J.A. Pinaire, and A. Reifel-Miller Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome PPAR Res. 2007 2007 94156
90. T.W. Pols, R. Ottenhoff, M. Vos, J.H. Levels, P.H. Quax, J.C. Meijers, H. Pannekoek, A.K. Groen, and C.J. de Vries Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity Biochem. Biophys. Res. Commun. 366 2008 910 916
91. B. Ponugoti, D.H. Kim, Z. Xiao, Z. Smith, J. Miao, M. Zang, S.Y. Wu, C.M. Chiang, T.D. Veenstra, and J.K. Kemper SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism J. Biol. Chem. 285 2010 33959 33970
92. J. Prawitt, M. Abdelkarim, J.H. Stroeve, I. Popescu, H. Duez, V.R. Velagapudi, J. Dumont, E. Bouchaert, T.H. van Dijk, and A. Lucas Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity Diabetes 60 2011 1861 1871
93. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev. 14 2000 2819 2830
94. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L.A. Pennacchio, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat. Genet. 40 2008 1461 1465
95. A.J. Rose, A. Vegiopoulos, and S. Herzig Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations J. Steroid Biochem. Mol. Biol. 122 2010 10 20
96. A.J. Rose, M.B. Díaz, A. Reimann, J. Klement, T. Walcher, A. Krones-Herzig, O. Strobel, J. Werner, A. Peters, and A. Kleyman Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor Cell Metab. 14 2011 123 130
97. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277
98. A. Sanyal, S. Mudaliar, R. Henry, H. Marchall, L. Morrow, C. Sciacca, P. Dillon, P. Clopton, M. Kipnes, and D. Shapiro A new therapy for nonalcoholic fatty liver disease and diabetes? INT 747 - the first FXR hepatic therapeutic study Hepatology 50 2009 389a 390a
99. A. Seppälä-Lindroos, S. Vehkavaara, A.M. Häkkinen, T. Goto, J. Westerbacka, A. Sovijärvi, J. Halavaara, and H. Yki-Järvinen Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men J. Clin. Endocrinol. Metab. 87 2002 3023 3028 (Pubitemid 34816338)
100. H. Shimano, I. Shimomura, R.E. Hammer, J. Herz, J.L. Goldstein, M.S. Brown, and J.D. Horton Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene J. Clin. Invest. 100 1997 2115 2124 (Pubitemid 27459368)
101. I. Shimomura, Y. Bashmakov, and J.D. Horton Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus J. Biol. Chem. 274 1999 30028 30032
102. E.S. Shin, H.H. Lee, S.Y. Cho, H.W. Park, S.J. Lee, and T.R. Lee Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells J. Nutr. 137 2007 1127 1131
103. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J. Clin. Invest. 116 2006 1793 1801 (Pubitemid 44033299)
104. C.J. Sinal, M. Tohkin, M. Miyata, J.M. Ward, G. Lambert, and F.J. Gonzalez Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 2000 731 744
105. G. Solinas, C. Vilcu, J.G. Neels, G.K. Bandyopadhyay, J.L. Luo, W. Naugler, S. Grivennikov, A. Wynshaw-Boris, M. Scadeng, J.M. Olefsky, and M. Karin JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity Cell Metab. 6 2007 386 397 (Pubitemid 350012000)
106. E.A. Sotaniemi, and I. Karvonen Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency Diabetes Res. 11 1989 131 139 (Pubitemid 20043679)
107. G. Stallone, B. Infante, G. Grandaliano, and L. Gesualdo Management of side effects of sirolimus therapy Transplantation 87 8, Suppl 2009 S23 S26
108. N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, and H.U. Häring Identification and characterization of metabolically benign obesity in humans Arch. Intern. Med. 168 2008 1609 1616
109. T. Takiishi, C. Gysemans, R. Bouillon, and C. Mathieu Vitamin D and diabetes Endocrinol. Metab. Clin. North Am. 39 2010 419 446
110. H. Tilg, and A.R. Moschen Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol. Metab. 19 2008 371 379
111. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Annu. Rev. Biochem. 77 2008 289 312
112. P. Tontonoz, J.B. Kim, R.A. Graves, and B.M. Spiegelman ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation Mol. Cell. Biol. 13 1993 4753 4759
113. K. Ueki, T. Kondo, Y.H. Tseng, and C.R. Kahn Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse Proc. Natl. Acad. Sci. USA 101 2004 10422 10427 (Pubitemid 38924941)
114. M. Vaxillaire, and P. Froguel Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes Endocr. Rev. 29 2008 254 264 (Pubitemid 351679698)
115. M. Wan, K.F. Leavens, D. Saleh, R.M. Easton, D.A. Guertin, T.R. Peterson, K.H. Kaestner, D.M. Sabatini, and M.J. Birnbaum Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c Cell Metab. 14 2011 516 527
116. M. Watanabe, S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, R.A. Heyman, D.D. Moore, and J. Auwerx Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J. Clin. Invest. 113 2004 1408 1418 (Pubitemid 39071696)
117. M. Watanabe, S.M. Houten, C. Mataki, M.A. Christoffolete, B.W. Kim, H. Sato, N. Messaddeq, J.W. Harney, O. Ezaki, and T. Kodama Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 2006 484 489 (Pubitemid 43152840)
118. M. Watanabe, Y. Horai, S.M. Houten, K. Morimoto, T. Sugizaki, E. Arita, C. Mataki, H. Sato, Y. Tanigawara, and K. Schoonjans Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure J. Biol. Chem. 286 2011 26913 26920
119. N. Yahagi, H. Shimano, A.H. Hasty, T. Matsuzaka, T. Ide, T. Yoshikawa, M. Amemiya-Kudo, S. Tomita, H. Okazaki, and Y. Tamura Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice J. Biol. Chem. 277 2002 19353 19357 (Pubitemid 34967441)
120. G. Yang, L. Badeanlou, J. Bielawski, A.J. Roberts, Y.A. Hannun, and F. Samad Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am. J. Physiol. Endocrinol. Metab. 297 2009 E211 E224
121. Z.X. Yang, W. Shen, and H. Sun Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease Hepatol Int. 4 2010 741 748
122. J.L. Yecies, H.H. Zhang, S. Menon, S. Liu, D. Yecies, A.I. Lipovsky, C. Gorgun, D.J. Kwiatkowski, G.S. Hotamisligil, C.H. Lee, and B.D. Manning Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways Cell Metab. 14 2011 21 32
123. T. Yoshikawa, H. Shimano, M. Amemiya-Kudo, N. Yahagi, A.H. Hasty, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, and K. Ohashi Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter Mol. Cell. Biol. 21 2001 2991 3000 (Pubitemid 32298367)
124. Y. Zhang, F.Y. Lee, G. Barrera, H. Lee, C. Vales, F.J. Gonzalez, T.M. Willson, and P.A. Edwards Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice Proc. Natl. Acad. Sci. USA 103 2006 1006 1011 (Pubitemid 43212212)
125. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, and N. Fujii Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174 (Pubitemid 32995375)